Reversible central respiratory events induced by valproic acid treatment: A case report

• Published in: SAGE open medical case reports Vol. 12; p. 2050313X241248386
• Main Authors: Moussa, Chirine, Mahmoud, Nour, Rouis, Houda, Khattab, Amel, Khouaja, Ibtihel, Bayahi, Leila, Zendah, Ines, Maâlej, Sonia
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01-01-2024; Sage Publications Ltd; SAGE Publishing
• Subjects: Case Report; Valproic acid; sleep apnea; drug side effects
• ISSN: 2050-313X; 2050-313X
• DOI: 10.1177/2050313X241248386

Valproic acid holds a prominent position as the primary therapeutic option for epilepsy cases. The utilization of antiepileptic agents like valproic acid has been linked to disturbances in sleep architecture. Although scant, there exists a subset of studies that allude to the potential manifestation of sleep apnea as an adverse effect of valproic acid administration. In this context, we present a case report of a 76-year-old man with a past medical history of arterial hypertension, atrial fibrillation, and obstructive sleep apnea syndrome treated with continuous positive airway pressure since 2020. Following the commencement of valproic acid treatment for vascular epilepsy, obstructive sleep apnea evolved toward to central sleep apnea. This case exemplifies the need for a heightened awareness of the multifaceted implications of valproic acid therapy on sleep patterns.